Cloud-based “AI” cardiac monitoring-analysis web service gets U.S. go ahead
Cardio
First U.S. Cases of Protected TAVR Using the Sentinel
Claret Medical reports first post-approval use at Cedars-Sinai, Cleveland Clinic, NewYork-Presbyterian, and Mount Sinai Heart
FDA Clearance and Launch of OrbusNeich Coronary Dilatation Catheters
Announcement marks company’s official entry into the US market
FDA Clears Claret Medical’s Sentinel Cerebral Protection System
First and only embolic protection device shown to reduce TAVR procedural strokes by 63 Percent
BioCardia® Helix Results in Higher Stem Cell Retention in Myocardium
BioCardia’s Helix transendocardial delivery system outperforms direct injection in newly published study
Positive First Clinical Data for Edwards Centera Transcatheter Heart Valve
Late-breaking at EuroPCR 2017 new 30-day results are the first data presented on the self-expanding Edwards CENTERA valve
Five Years and 1600 Patients: Study Aims to Inform TAVI vs Surgery Decision
Comparative study on main categories heart valve replacement techniques aims to deliver objectivity
Abbott Says Newly CE Marked Confirm Rx™ ICM Represents New Paradigm
Device automatically captures vital cardiac information and relays data to physicians via smartphone app, enabling remote monitoring of irregular hearth rhythms
FDA Clears Teleflex Arrow® AC3 Optimus™ Intra-Aortic Balloon Pump
Teleflex claims advanced IABP performance with the ability to provide optimized therapy to the most challenging patient conditions
New Data Supports Perceval™ for Aortic Valve Replacement in Aortic Stenosis Patients
LivaNova also says data presented at AATS reinforces the Memo 3D ReChord as safe and effective for mitral valve repair procedures
RTI Surgical® Tissue Matrix Line Extensions for International Markets
RTI will now offer a more pliable version of its Fortiva Tissue Matrix
REFLECT Study Investigates Whether TriGuard™ Reduces Stroke Risk During TAVR
Pivotal international study aims to support FDA approval of cerebral protection device
Boston Scientific to Acquire Symetis
Company says acquisition demonstrates continued commitment to structural heart portfolio
CE Mark for REVA’s Fantom Drug-Eluting Bioresorbable Stent
European launch of Fantom coronary stent underway
Coronary Atherectomy Trial Sees First Patient
Cardiovascular Systems enrolls first subject in ECLIPSE coronary clinical trial
FDA Approves Medtronic CoreValve™ Evolut™ Pro Transcatheter Valve
First-ever data at ACC.17 confirms safety and efficacy of new self-expanding, recapturable heart valve at 30-days with high survival, low stroke and minimal paravalvular leak